Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Profound Medical Q4 EPS $(0.20) Beats $(0.33) Estimate, Sales $4.18M Miss $4.27M Estimate

Author: Benzinga Newsdesk | March 06, 2025 04:18pm
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.33) by 39.39 percent. This is a 52.38 percent increase over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $4.18 million which missed the analyst consensus estimate of $4.27 million by 2.10 percent. This is a 108.85 percent increase over sales of $2.00 million the same period last year.

Posted In: PROF


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist